- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
UPDATED Jun 27, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
954 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ARCOMA | SEK 17.90 | 6.5% | 88.4% | SEK 236.0m | SEK 15.00 | PE25.1x | E20.5% | n/a | Healthcare | ||
HTCR | US$0.70 | -0.7% | -51.8% | US$14.2m | US$3.00 | PB3.7x | E163.1% | 11.4% | Software | ||
SMRT | RM 0.94 | -1.6% | 24.3% | RM 414.5m | RM 1.32 | PE723.9x | E49.0% | 0% | Consumer Services | ||
PNL | €1.28 | -7.6% | -18.6% | €637.0m | €1.29 | PE20.5x | E24.2% | 7.0% | Transportation | ||
FODELIA | €5.88 | 4.3% | 39.7% | €47.4m | €6.50 | PE39.4x | E28.5% | 1.4% | Food, Beverage & Tobacco | ||
CUP | AU$0.56 | 5.7% | 2.8% | AU$92.3m | AU$1.36 | PE15.8x | E40.5% | 6.8% | Commercial Services | ||
EDAC | €8.76 | -8.8% | -44.9% | €73.3m | €18.10 | PE11.7x | E27.1% | 1.7% | Capital Goods | ||
TRUE B | SEK 34.52 | -3.0% | 18.6% | SEK 11.9b | SEK 54.50 | PE21.3x | E17.6% | 1.2% | Software | ||
A119610 | ₩24,900.00 | 0% | -31.5% | ₩312.1b | ₩43,250.00 | PE27.1x | E58.4% | 2.4% | Healthcare | ||
1801 | HK$36.80 | 0% | 24.3% | HK$63.6b | HK$55.54 | PS9x | E50.8% | n/a | Pharmaceuticals & Biotech | ||
1359 | HK$0.65 | -9.7% | -16.7% | HK$26.3b | n/a | PE5.4x | E20.2% | 7.6% | Diversified Financials | ||
KIE | UK£1.37 | -1.7% | 83.6% | UK£618.6m | UK£1.93 | PE15.4x | E22.4% | 2.4% | Capital Goods | ||
HSAI | US$4.24 | -2.3% | -59.3% | US$554.5m | US$10.07 | PS2.2x | E71.0% | n/a | Automobiles | ||
5726 | JP¥2,795.00 | -0.5% | -4.9% | JP¥102.9b | JP¥4,450.00 | PE10.6x | E11.6% | 2.5% | Materials | ||
MILDEF | SEK 66.50 | -2.9% | -0.7% | SEK 2.7b | SEK 89.00 | PE64.2x | E47.7% | 0.8% | Capital Goods | ||
EDV | CA$28.86 | -2.6% | -8.2% | CA$7.0b | CA$40.13 | PS2.4x | E46.0% | 3.8% | Materials | ||
CTH1V | €3.08 | 1.0% | 8.5% | €29.9m | €3.60 | PE19.3x | E45.6% | n/a | Capital Goods | ||
300143 | CN¥7.40 | 1.2% | -34.7% | CN¥4.7b | CN¥10.12 | PE53.9x | E28.5% | 0% | Healthcare | ||
4551 | NT$111.50 | -2.2% | -29.4% | NT$12.8b | NT$113.71 | PE24.3x | E31.3% | 2.2% | Automobiles | ||
RAY B | SEK 142.00 | 1.4% | 117.5% | SEK 4.9b | SEK 195.00 | PE48.3x | E33.6% | 0.5% | Healthcare | ||
LAB B | Mex$16.81 | -0.4% | 22.7% | Mex$15.9b | Mex$19.50 | PE15.2x | E28.6% | 4.7% | Pharmaceuticals & Biotech | ||
ELK | NOK 20.16 | -2.6% | -17.6% | NOK 12.8b | NOK 25.60 | PB0.5x | E92.8% | 0% | Materials | ||
TCM | €2.00 | -2.0% | -43.2% | €17.2m | €5.00 | PS1.2x | E98.3% | n/a | Real Estate Management and Development | ||
A101390 | ₩6,880.00 | -2.7% | -16.6% | ₩68.5b | n/a | PB3.1x | E106.3% | n/a | Tech |